semaglutide injection vials Compound Semaglutide Injections | Semaglutide Delivered
Description
Nearly Half of Patients Lose 30% of Body Weight The 45.3% responder rate at 30% is the number that matters most for patients
10.1089/ars.2010.3253 [DOI] [PMC free article] [PubMed] [Google Scholar] 35
Answer: In a 48-week phase 2 trial, participants on the highest retatrutide doses lost up to roughly 24 percent of body weight, a figure that exceeded results reported for currently approved single and dual agonists
Once pharmacological treatment is initiated and proves effective, it should not be arbitrarily time-limitedjust as we would not discontinue treatment for diabetes, hypertension, or other chronic diseases
